- Home
- AIXI vs TPST Comparison
AIXI vs TPST Comparison
Compare AIXI & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIXI
- TPST
- Stock Information
- Founded
- AIXI 2001
- TPST 2011
- Country
- AIXI China
- TPST United States
- Employees
- AIXI N/A
- TPST N/A
- Industry
- AIXI Computer Software: Prepackaged Software
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- AIXI Technology
- TPST Health Care
- Exchange
- AIXI Nasdaq
- TPST Nasdaq
- Market Cap
- AIXI 31.2M
- TPST 33.0M
- IPO Year
- AIXI 2023
- TPST N/A
- Fundamental
- Price
- AIXI $1.84
- TPST $6.31
- Analyst Decision
- AIXI
- TPST Hold
- Analyst Count
- AIXI 0
- TPST 3
- Target Price
- AIXI N/A
- TPST $30.00
- AVG Volume (30 Days)
- AIXI 195.8K
- TPST 70.7K
- Earning Date
- AIXI 05-15-2025
- TPST 08-07-2025
- Dividend Yield
- AIXI N/A
- TPST N/A
- EPS Growth
- AIXI N/A
- TPST N/A
- EPS
- AIXI N/A
- TPST N/A
- Revenue
- AIXI $70,314,315.00
- TPST N/A
- Revenue This Year
- AIXI $26.84
- TPST N/A
- Revenue Next Year
- AIXI N/A
- TPST N/A
- P/E Ratio
- AIXI N/A
- TPST N/A
- Revenue Growth
- AIXI 18.84
- TPST N/A
- 52 Week Low
- AIXI $1.81
- TPST $5.35
- 52 Week High
- AIXI $8.31
- TPST $28.34
- Technical
- Relative Strength Index (RSI)
- AIXI 35.26
- TPST 42.85
- Support Level
- AIXI $1.81
- TPST $6.57
- Resistance Level
- AIXI $2.17
- TPST $6.80
- Average True Range (ATR)
- AIXI 0.29
- TPST 0.25
- MACD
- AIXI -0.04
- TPST -0.06
- Stochastic Oscillator
- AIXI 13.18
- TPST 10.33
About AIXI XIAO-I Corporation
XIAO-I Corp is an AI industrialization company focusing on the AI Cognitive Intelligence platform. The platform combines six core technologies including Natural Language Processing, Speech Processing, Computer Vision, Machine Learning, Affective Computing, Data Intelligence, and Hyper- automation. Based on the platform, The company developed products and solutions in the fields of Al+ Contact Center, Al+ Finance, Al+ City Public Service, Al+ Architecture, Al+ Metaverse, Al+ Manufacturing, and Al+ Healthcare. It generates revenue from the sale of software products and services, M&S services, and the sale of cloud platform products.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.